Whole genome bisulfite sequencing of cell-free DNA and its cellular contributors uncovers placenta hypomethylated domains

Abstract

BackgroundCirculating cell-free fetal DNA has enabled non-invasive prenatal fetal aneuploidy testing without direct discrimination of the maternal and fetal DNA. Testing may be improved by specifically enriching the sample material for fetal DNA. DNA methylation may allow for such a separation of DNA; however, this depends on knowledge of the methylomes of circulating cell-free DNA and its cellular contributors.ResultsWe perform whole genome bisulfite sequencing on a set of unmatched samples including circulating cell-free DNA from non-pregnant and pregnant female donors and genomic DNA from maternal buffy coat and placenta samples. We find CpG cytosines within longer fragments are more likely to be methylated. Comparison of the methylomes of placenta and non-pregnant circulating cell-free DNA reveal many of the 51,259 identified differentially methylated regions are located in domains exhibiting consistent placenta hypomethylation across millions of consecutive bases. We find these placenta hypomethylated domains are consistently located within regions exhibiting low CpG and gene density. Differentially methylated regions identified when comparing placenta to non-pregnant circulating cell-free DNA are recapitulated in pregnant circulating cell-free DNA, confirming the ability to detect differential methylation in circulating cell-free DNA mixtures.ConclusionsWe generate methylome maps for four sample types at single-base resolution, identify a link between DNA methylation and fragment length in circulating cell-free DNA, identify differentially methylated regions between sample groups, and uncover the presence of megabase-size placenta hypomethylated domains.Electronic supplementary materialThe online version of this article (doi:10.1186/s13059-015-0645-x) contains supplementary material, which is available to authorized users.

Impacts of bisphenol A (BPA) and phthalate exposures on epigenetic outcomes in the human placenta

“…The reasons for this are numerous, but include the fact that exposure assessment across pregnancy is challenging, and investigating direct relationships between chemical exposures and placental epigenetic disruption are complicated by the placenta’s unique epigenetic signature. This includes temporal shifts in epigenetic marks across gestation [ 121 ], relative genomic hypomethylation driven by the placenta’s unique methylation machinery signature [ 122–125 ], differential genomic imprinting [ 126 ], and seemingly unique intragenic vs. gene body methylation patterns [ 127 ] when compared to other tissues (reviewed extensively in [ 128 ]). If the goal is to more-deeply interrogate the epigenetic effects of environmental chemicals on the placenta, entirely unique approaches are needed for both the design of studies (e.g.…”

Estimating the rate of cell type degeneration from epigenetic sequencing of cell-free DNA

“…To do this, we download publicly available WGBS cfDNA of 7 pregnant and 8 non-pregnant women [42]. All women were between 11 and 25 weeks pregnant at time of cfDNA extraction.…”

Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten

“…Although WGBS has been widely accepted as the gold standard method to assay genome-wide DNA methylation, the high cost [ 22 ] and depth of sequencing required [ 27 ] make it a challenge for large-scale DNA methylation studies. Ever since the time WGBS was developed in 2009 the number of large-scale WGBS studies is limited [ 28 , 29 ], either small numbers of samples are studied at a high coverage [ 15 , 30 ] or larger numbers of samples are studied at low coverage [ 31 ]. One of the earliest publications on WGBS was performed at 30× coverage in order to compare the DNA methylation profiles of an embryonic stem cell and a fibroblast cell line [ 15 ].…”